Grant: Alliance Grants
McGill University
$30,000.00
Investigation of the effects of COVID-19 on the functional resting-state and respiratory-related organization of the brain using multimodal neuroimaging _x000d_ _x000d_ _x000d_ _x000d_
FY 2020-21
Summary
Since the outbreak of the COVID pandemic a year ago, it has become evident that the effects of the virus are not limited to the respiratory system and that several other organs, including the brain, heart, liver, skin and kidneys can be affected. In turn, COVID-19 causes a very wide range of symptoms, including neurological symptoms with some of these symptoms persisting several months after disease onset. Of particular interest are its effects on the brain. To this end, imaging has been used to study the effects of COVID on the brain and the results have suggested that many individuals suffer widespread damage in their brain tissue and that the extent of this damage is usually (but not always) related to the severity of the respiratory symptoms. The mechanisms that cause brain damage are also not understood yet. Importantly, almost all previous studies that have used neuroimaging to study the effects of COVID on the brain have used anatomical images, i.e. they have focused on brain structure. However, investigating the potential effects of COVID on brain function is also of great importance and yields significant potential for complementing anatomical studies. In this context, the main aim of the proposed work is to use neuroimaging to study brain function in COVID survivors. We will collect functional magnetic resonance imaging (fMRI) data both during the resting-state (i.e. subjects will just lie in the scanner), as well as during inhalation of mild carbon dioxide boluses and controlled breathing, when subjects will be instructed to breath at a specific rhythm and hold their breath. This will give us the opportunity to directly assess whether the processing of respiratory stimuli which take place in specific areas of the brain is affected by COVID. We will also collect anatomical images from all subjects and assess whether COVID effects on brain function and structure are related to each other. The proposed work will greatly enhance our knowledge on the wide range of symptoms caused by COVID, focusing on its potential effects on the functional organization of the brain and its respiratory control centers. In turn, this will contribute towards better, individualized short-term and long-term therapies.
Program
Alliance Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
560905-2020
Name nom
Mitsis, Georgios
Department département
Bioengineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Investigation of the effects of COVID-19 on the functional resting-state and respiratory-related organization of the brain using multimodal neuroimaging _x000d_
_x000d_
_x000d_
_x000d_
Keyword
NSERC
Application summary
Since the outbreak of the COVID pandemic a year ago, it has become evident that the effects of the virus are not limited to the respiratory system and that several other organs, including the brain, heart, liver, skin and kidneys can be affected. In turn, COVID-19 causes a very wide range of symptoms, including neurological symptoms with some of these symptoms persisting several months after disease onset. Of particular interest are its effects on the brain. To this end, imaging has been used to study the effects of COVID on the brain and the results have suggested that many individuals suffer widespread damage in their brain tissue and that the extent of this damage is usually (but not always) related to the severity of the respiratory symptoms. The mechanisms that cause brain damage are also not understood yet. Importantly, almost all previous studies that have used neuroimaging to study the effects of COVID on the brain have used anatomical images, i.e. they have focused on brain structure. However, investigating the potential effects of COVID on brain function is also of great importance and yields significant potential for complementing anatomical studies. In this context, the main aim of the proposed work is to use neuroimaging to study brain function in COVID survivors. We will collect functional magnetic resonance imaging (fMRI) data both during the resting-state (i.e. subjects will just lie in the scanner), as well as during inhalation of mild carbon dioxide boluses and controlled breathing, when subjects will be instructed to breath at a specific rhythm and hold their breath. This will give us the opportunity to directly assess whether the processing of respiratory stimuli which take place in specific areas of the brain is affected by COVID. We will also collect anatomical images from all subjects and assess whether COVID effects on brain function and structure are related to each other. The proposed work will greatly enhance our knowledge on the wide range of symptoms caused by COVID, focusing on its potential effects on the functional organization of the brain and its respiratory control centers. In turn, this will contribute towards better, individualized short-term and long-term therapies.